Gaining FDA approval for its epinephrine nasal spray came nearly a year later than expected for ARS Pharmaceuticals. But after the recent approval of neffy, the San Diego drugmaker is poised for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback